Related Experiment Videos
[Chemokines in central nervous system pathology]
1Katedry i Kliniki Neurologii Akademii Medycznej w Lodzi. aglabinski@afazja.am.lodz.pl
Neurologia I Neurochirurgia Polska
|December 28, 1999
Summary
Chemokines, inflammatory cytokines, drive leukocyte movement and are implicated in central nervous system (CNS) diseases. Targeting these molecules offers potential therapeutic strategies for neurological disorders.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Context:
- Chemokines are pro-inflammatory cytokines that regulate leukocyte migration.
- Their role in the central nervous system (CNS) is increasingly recognized.
- Elevated chemokine expression is observed in CNS injury and disease models.
Purpose:
- To review the involvement of chemokines in CNS pathology.
- To highlight chemokines as potential therapeutic targets for neurological diseases.
Summary:
- Chemokines are key mediators of inflammatory processes, influencing leukocyte behavior.
- Evidence links chemokines to the pathogenesis of autoimmune and infectious CNS inflammation.
- Experimental models of brain injury and ischemia show increased chemokine expression.
- Cultured CNS cells can produce chemokines, underscoring their local relevance.
Impact:
- Chemokines are significant contributors to CNS pathology.
- Targeting chemokines presents a promising therapeutic avenue for neurological conditions.